EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Minimal Residual Disease Detection: Bridging Molecular and Clinical Strategies for Recurrence Prevention in Gynecologic Cancers

Andi Darma Putra iD, Naufal Syafiq Darmawan iD, Aldi Tamara Rahman iD, Lasmini Syariatin iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311708 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Andi Darma Putra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecology-Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Ce…. Hauptthemen laut MEDLINE: Neoplasm, Residual, Genital Neoplasms, Female, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gynecologic cancers remain a major global health burden, particularly in low- and middle-income countries, with high incidence and mortality rates around 45–50%. The detection of minimal residual disease (MRD) is transforming the management of recurrence risk in gynecologic cancers through highly sensitive molecular technologies. MRD encompasses small populations of residual cancer cells or post-treatment molecular traces but remain undetectable by conventional methods. Its detection relies on circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and advanced next-generation sequencing (NGS), with ctDNA-based MRD assays having sensitivity levels between 85% and over 99%. Other technologies, such as liquid biopsies and digital PCR, are also in development. MRD status has demonstrated high predictors of recurrence and survival with positive MRD strongly associated with poor outcomes and negative MRD indicates sustained remission. However, MRD detection faces significant limitations, such as tumor heterogeneity, inconstant ctDNA levels, technical issues of false-negative results, and limited clinical accessibility. Therefore, this review presents current evidence regarding the molecular detection of MRD in gynecologic malignancies and assesses its prognostic and predictive relevance. Ultimately, MRD continuous integration into clinical practice offers a promising modality to enable early relapse detection, more precise therapeutic decision-making, and the improvement of personalized medicine access to gynecologic cancers worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm, ResidualGenital Neoplasms, FemaleNeoplasm Recurrence, LocalHumansFemaleCirculating Tumor DNABiomarkers, TumorNeoplastic Cells, CirculatingHigh-Throughput Nucleotide SequencingPrognosisLiquid Biopsy

Stichwörter der Autor:innen

cancer detectioncancer recurrencecirculating tumor DNAcirculating tumor cellsgynecologic cancerminimal residual disease

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Division of Gynecology-Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Central Jakarta 10430, Indonesia.
  • Dopamine Science Institute, Pancoran Mas, Depok 16431, Indonesia.
  • Assistant Division of Gynecology-Oncology, Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Central Jakarta 10430, Indonesia.

ORCID-Profile: Andi Darma Putra, Naufal Syafiq Darmawan, Aldi Tamara Rahman, Lasmini Syariatin

Zitieren

APA

Putra, A. D., Darmawan, N. S., Rahman, A. T., & Syariatin, L. (2025). Minimal Residual Disease Detection: Bridging Molecular and Clinical Strategies for Recurrence Prevention in Gynecologic Cancers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311708

Vancouver

Putra AD, Darmawan NS, Rahman AT, Syariatin L. Minimal Residual Disease Detection: Bridging Molecular and Clinical Strategies for Recurrence Prevention in Gynecologic Cancers. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311708

BibTeX
@article{Putra2025,
  author = {Putra, Andi Darma and Darmawan, Naufal Syafiq and Rahman, Aldi Tamara and Syariatin, Lasmini},
  title = {Minimal Residual Disease Detection: Bridging Molecular and Clinical Strategies for Recurrence Prevention in Gynecologic Cancers},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311708}
}
Kostenlos starten →